Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 August 2020 | Story Xolisa Mnukwa
SRC election term extended

SRC elections 2020/21 were due to take place before the end of August 2020 as prescribed by the ISRC constitution. However, owing to the COVID-19 pandemic, and the consequent lockdown regulations and extension of the UFS 2020 academic year, the current SRC term will be extended until March 2021.

The decision to extend the term of the SRC was taken by the Rectorate following a recommendation made by the Division of Student Affairs (DSA), after consultation with
the ISRC. 

The consultation process with the ISRC produced three options:
  • Proceed with SRC elections in August 2020;
  • Extend the current SRC term to align with the extended 2020 academic year; or
  • Elect a Transitional Student Council (TSC) from September 2020 to March 2021.
In view of the above, and considering current conditions amid the coronavirus pandemic,
online SRC elections are scheduled for March 2021. 

This extension implies that the terms of all the sub-structures of the ISRC will be extended accordingly.

This communication serves as official notice to the Student Body about the extension of the
2019/2020 ISRC term and all its sub-structures as per the prescripts of the ISRC Constitution.

The DSA, with particular reference to the Student Governance Office (SGO), remains
committed to engaging with all parties of legitimate interest about matters arising from,
related to, and/or about SRC elections in all its permutations. 

Should you have any questions or comments, please feel free to contact the SGO:
Coordinator: Kamogelo Dithebe (DithebeKS@ufs.ac.za)
Faculty Coordinator: (MunzheleleD@ufs.ac.za)
Administrator: Rethabile Motseki (MotsekiR@ufs.ac.za)

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept